These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 14523403)

  • 1. In praise of Gates.
    Nature; 2003 Oct; 425(6957):435. PubMed ID: 14523403
    [No Abstract]   [Full Text] [Related]  

  • 2. Gates steps up war on malaria with donation of 168 million dollars.
    Butler D
    Nature; 2003 Sep; 425(6956):331. PubMed ID: 14508444
    [No Abstract]   [Full Text] [Related]  

  • 3. Biomedical philanthropy: state of the donation.
    Wadman M
    Nature; 2007 May; 447(7142):248-50. PubMed ID: 17507953
    [No Abstract]   [Full Text] [Related]  

  • 4. Global disease fund hit by cash crisis.
    Butler D
    Nature; 2010 Oct; 467(7317):767. PubMed ID: 20944709
    [No Abstract]   [Full Text] [Related]  

  • 5. HIV/AIDS: as the US crisis continues, funders respond.
    Prina LL
    Health Aff (Millwood); 2014 Mar; 33(3):515-6. PubMed ID: 24590952
    [No Abstract]   [Full Text] [Related]  

  • 6. Charities seek cut of drug royalties.
    Ledford H
    Nature; 2011 Jul; 475(7356):275-6. PubMed ID: 21776052
    [No Abstract]   [Full Text] [Related]  

  • 7. Global health--the Gates-Buffett effect.
    Okie S
    N Engl J Med; 2006 Sep; 355(11):1084-8. PubMed ID: 16971714
    [No Abstract]   [Full Text] [Related]  

  • 8. Philanthropic funding in cerebral palsy research: translating new knowledge into improved quality of life.
    Nielsen JB; Sinkjaer T
    Dev Med Child Neurol; 2021 Feb; 63(2):125. PubMed ID: 33393701
    [No Abstract]   [Full Text] [Related]  

  • 9. Aid fund faces cash crunch.
    Butler D
    Nature; 2010 Jan; 463(7280):415. PubMed ID: 20110960
    [No Abstract]   [Full Text] [Related]  

  • 10. Funding: Donor drugs.
    Willyard C
    Nature; 2016 May; 533(7601):S43-5. PubMed ID: 27144609
    [No Abstract]   [Full Text] [Related]  

  • 11. A firm response to AIDS.
    Nature; 2006 Oct; 443(7113):738-9. PubMed ID: 17051178
    [No Abstract]   [Full Text] [Related]  

  • 12. Gates of opportunity.
    Sorenson E
    Nature; 2007 May; 447(7143):502-3. PubMed ID: 17554811
    [No Abstract]   [Full Text] [Related]  

  • 13. Global health hits crisis point.
    Garrett L
    Nature; 2012 Feb; 482(7383):7. PubMed ID: 22297931
    [No Abstract]   [Full Text] [Related]  

  • 14. Changing funding patterns in tuberculosis.
    Kaufmann SH; Parida SK
    Nat Med; 2007 Mar; 13(3):299-303. PubMed ID: 17342144
    [No Abstract]   [Full Text] [Related]  

  • 15. Developing-world health: the fightback starts here.
    Butler D
    Nature; 2003 Dec; 426(6968):754. PubMed ID: 14685194
    [No Abstract]   [Full Text] [Related]  

  • 16. The philanthropic principle.
    Smaglik P
    Nature; 2004 Oct; 431(7009):719. PubMed ID: 15470433
    [No Abstract]   [Full Text] [Related]  

  • 17. Thinking big about global health.
    Chen I
    Cell; 2006 Feb; 124(4):661-3. PubMed ID: 16497574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. African science feels the pinch.
    Nordling L
    Nature; 2009 Oct; 461(7268):1180. PubMed ID: 19865131
    [No Abstract]   [Full Text] [Related]  

  • 19. Freedom to fund.
    Aschwanden C
    Cell; 2007 Feb; 128(3):421-3. PubMed ID: 17289559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why I raise money for kidney disease research.
    Ditschman EP
    Nephrol News Issues; 2007 Aug; 21(9):56. PubMed ID: 17722858
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.